The Joint Corp stock: Q3 profit improves as sales outlook is cut

Published on 11/12/2026 at 02:03 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

The Joint Corp stock faces a weaker sales outlook after third-quarter results. Profitability from continuing operations improved as refranchising advanced.

Profit improves as sales outlook weakens

Third-quarter revenue increased modestly, while system-wide sales and comparable sales declined.
Continuing-operations profitability improved, supported by the transition toward a capital-light franchisor model.
Management maintained its adjusted EBITDA outlook despite lowering full-year sales expectations.

JYNT, US47973J1025, Illustration mit AI erstellt.

The Joint Corp. reported its third-quarter results on November 5, 2026, after the U.S. market close. In its GlobeNewswire release, the chiropractic clinic franchisor reported higher revenue but weaker system-wide sales and reduced its full-year sales outlook.

Revenue edges higher as demand softens

Revenue rose 1 percent year over year to 13.6 million U.S. dollars for the quarter ended September 30, 2026. System-wide sales fell 3.1 percent to 123.3 million U.S. dollars, while comparable sales declined 1.9 percent, an improvement from a 2.8 percent decline in the second quarter.

Management attributed the pressure on comparable sales to lower average patient spending and fewer new patients. Growth in active membership and higher lifetime value per active member provided support, but did not offset the weaker demand environment.

Refranchising lifts continuing operations

Net income from continuing operations increased to 1.5 million U.S. dollars from 290,000 U.S. dollars a year earlier. Adjusted EBITDA from continuing operations rose to 2.3 million U.S. dollars from 1.4 million U.S. dollars. On a consolidated basis, however, The Joint recorded a net loss of 117,000 U.S. dollars, compared with net income of 855,000 U.S. dollars in the prior-year quarter, reflecting discontinued operations.

The company operated 930 clinics at September 30, including 915 franchised locations and 15 company-owned or managed clinics. It opened four clinics, closed 15 and refranchised 26 during the quarter, reinforcing its shift toward a capital-light, pure-play franchisor structure.

Lower sales guidance raises execution pressure

The Joint lowered its 2026 system-wide sales outlook to 508 million to 512 million U.S. dollars from a previous range of 519 million to 552 million U.S. dollars. Comparable sales are now expected to decline between 2.5 percent and 3.5 percent, compared with the previous range of a 3 percent decline to 3 percent growth.

Consolidated adjusted EBITDA guidance remained at 12.5 million to 13.5 million U.S. dollars. The company also expects its year-end clinic count to be about 50 locations below the 2025 year-end level. For investors, the key issue is whether membership and retention gains can restore sales growth as the refranchising program nears completion.

The Joint Corp. business model

The Joint Corp. is headquartered in Scottsdale, Arizona, and operates, manages and franchises The Joint Chiropractic clinics across the United States. Its model combines chiropractic care, membership plans, convenient locations and a cash-based approach that does not require insurance. The company said it had more than 14 million patient visits annually and over 925 locations in its corporate overview.